These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8761438)

  • 1. Sulindac suppresses tumorigenesis in the Min mouse.
    Beazer-Barclay Y; Levy DB; Moser AR; Dove WF; Hamilton SR; Vogelstein B; Kinzler KW
    Carcinogenesis; 1996 Aug; 17(8):1757-60. PubMed ID: 8761438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.
    Mahmoud NN; Boolbol SK; Dannenberg AJ; Mestre JR; Bilinski RT; Martucci C; Newmark HL; Chadburn A; Bertagnolli MM
    Carcinogenesis; 1998 Jan; 19(1):87-91. PubMed ID: 9472698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulindac effects on inflammation and tumorigenesis in the intestine of mice with Apc and Mlh1 mutations.
    Itano O; Yang K; Fan K; Kurihara N; Shinozaki H; Abe S; Jin B; Gravaghi C; Edelmann W; Augenlicht L; Kopelovich L; Kucherlapati R; Lamprecht S; Lipkin M
    Carcinogenesis; 2009 Nov; 30(11):1923-6. PubMed ID: 19755659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S; Halimi C; Caulin C; Bergmann JF
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulindac therapy of colorectal polyps in familial adenomatous polyposis.
    Tonelli F; Valanzano R; Dolara P
    Dig Dis; 1994; 12(5):259-64. PubMed ID: 7882547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.
    Ignatenko NA; Besselsen DG; Roy UK; Stringer DE; Blohm-Mangone KA; Padilla-Torres JL; Guillen-R JM; Gerner EW
    Nutr Cancer; 2006; 56(2):172-81. PubMed ID: 17474863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.
    Boolbol SK; Dannenberg AJ; Chadburn A; Martucci C; Guo XJ; Ramonetti JT; Abreu-Goris M; Newmark HL; Lipkin ML; DeCosse JJ; Bertagnolli MM
    Cancer Res; 1996 Jun; 56(11):2556-60. PubMed ID: 8653697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apc mice: models, modifiers and mutants.
    McCart AE; Vickaryous NK; Silver A
    Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.
    Esaki M; Matsumoto T; Mizuno M; Kobori Y; Yoshimura R; Yao T; Iida M
    Dis Colon Rectum; 2002 Oct; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Orner GA; Dashwood WM; Blum CA; Díaz GD; Li Q; Al-Fageeh M; Tebbutt N; Heath JK; Ernst M; Dashwood RH
    Mutat Res; 2002 Sep; 506-507():121-7. PubMed ID: 12351151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development.
    Davis JS; Kanikarla-Marie P; Gagea M; Yu PL; Fang D; Sebastian M; Yang P; Hawk E; Dashwood R; Lichtenberger LM; Menter D; Kopetz S
    BMC Cancer; 2020 Sep; 20(1):871. PubMed ID: 32912193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated
    Terasaki M; Hamoya T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
    Anticancer Res; 2021 Mar; 41(3):1299-1305. PubMed ID: 33788721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.
    Hisamuddin IM; Wehbi MA; Schmotzer B; Easley KA; Hylind LM; Giardiello FM; Yang VW
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2366-9. PubMed ID: 16214918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumorigenesis in the Apc(min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac.
    Orner GA; Dashwood WM; Blum CA; Díaz GD; Li Q; Dashwood RH
    Carcinogenesis; 2003 Feb; 24(2):263-7. PubMed ID: 12584176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.
    Yang VW; Geiman DE; Hubbard WC; Spannhake EW; Hylind LM; Hamilton SR; Giardiello FM
    Prostaglandins Other Lipid Mediat; 2000 Jan; 60(1-3):83-96. PubMed ID: 10680778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.
    Guillen-Ahlers H; Buechler SA; Suckow MA; Castellino FJ; Ploplis VA
    Carcinogenesis; 2008 Jul; 29(7):1421-7. PubMed ID: 18499699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.